Docetaxel + Cisplatin vs. Mitomycin, Vindesine + Cisplatin with Concurrent Thoracic Radiation Therapy for Locally Advanced NSCLC - ONA
Links shared publicly online about this topic.
- 242total visits
Docetaxel + Cisplatin vs. Mitomycin, Vindesine + Cisplatin with Concurrent Thoracic Radiation Therapy for Locally Advanced NSCLC - ONA
View full resource at oncologynurseadvisor.com
Tags: Cancer Medication, Lung Cancer, Non-Small Cell Lung Cancer, Lung, Phase 3 Clinical Trial, Taxotere, Radiation
Most Recently Shared on June 4, 2011 at 9:32 pm By:
Docetaxel + Cisplatin vs. Mitomycin, Vindesine + Cisplatin with Concurrent Thoracic Radiation… http://goo.gl/fb/DgZjb
Docetaxel + Cisplatin vs. Mitomycin, Vindesine + Cisplatin with Concurrent Thoracic Radiation Therapy for Locally Advanced NSCLC - MPR
empr.com — “A long-term follow up on a Phase 3 study for locally advanced non-small cell lung cancer showed that docetaxel and cisplatin chemotherapy with concurrent thoracic radiation therapy vs. mitomycin, vindesine, and cisplatin therapy seemed more efficacious during early period, however the benefit disappeared later, investigators report from the American Society of Clinical Oncology’s 11th Annual Meeting.” View full resource at empr.com
Most Recently Shared on June 4, 2011 at 10:00 pm By:
MPR News: Docetaxel + Cisplatin vs. Mitomycin, Vindesine + Cisplatin with Concurrent Thoracic Radiation Therapy ... http://bit.ly/klxaj9
Advertisement
